Abstract
This chapter focuses on the identification of opinion leaders in physician networks as a substantial opportunity for pharmaceutical firms rethinking their business model, and looking for improving resource allocation in order to increase their return on investment. It points out the various challenges and the advantages of identifying regional opinion leaders, especially when it comes to sustained use of branded drugs marketed by pharmaceutical firms. It includes a basic overview of network structure and the formation of physician social networks. This is a growing area of importance for various disciplines such as epidemiology, sociology, economics, and marketing. In this chapter, the reader will get introduced to several models of physician social networks which help isolate and measure the effect of opinion leaders, both self-stated and those identified by patient referral data. The author points out the managerial implications of this stream of research and promising areas of opportunity for deeper analysis for this promising nascent research stream.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aral S (2011) Identifying social influence: a comment on opinion leadership and social contagion in new product diffusion. Mark Sci 30(2):217–223
Bala V, Goyal S (2000) A non-cooperative model of network formation. Econometrica 68:1181–1229
Bass FM (1969) A new product growth model for consumer durables. Mark Sci 15(5):215–227
Bell DR, Song S (2007) Social contagion and trial on the internet: evidence from online grocery retailing. Quant Mark Econ 5(4):361–400
Bhatia T, Wang LK (2011) Identifying physician peer-to-peer effects using patient movement data. Int J Res Mark 28(1):51–61
Blume LE (1993) The statistical mechanics of strategic interaction. Games Econ Behav 5(3):387–424
Brock WA, Durlauf SN (2001) Discrete choice with social interactions. Rev Econ Stud 68(4):235–260
Brock WA, Durlauf SN (2002) A multinomial-choice model of neighborhood effects. Am Econ Rev 92(2):298–303
Burt RS (1987) Social contagion and innovation: cohesion versus structural equivalence. Am J Sociol 92(6):1287–1335
Celentano DD, Bond KC, Lyles CM, Trakul SE, L-Go VF, Beyrer C, Chiangmai C, Nelson KE, Khamboonruang C, Vaddhanaphuti C (2000) Preventive intervention to reduce sexually transmitted infections. Arch Intern Med 160(4):535–540
Chritakis NA, Fowler JH (2011) Contagion in prescribing behavior among network of doctors. Mark Sci 30(2):213–216
Coleman JS, Katz E, Menzel H (1966) Medical innovation: a diffusion study. The Bobbs-Merrill Company, Indianapolis, IN
Conley TG, Udry CR (2010) Learning about a new technology: pineapple in Ghana. Am Econ Rev 100(1):35–69
Dodds PS, Watts DJ (2004) Universal behavior in a generalized model of contagion. Phys Rev Lett 92:218701–218705
Dodds PS, Watts DJ (2005) A generalized model of social and biological contagion. J Theor Biol 232:587–604
Dufflo E, Saez E (2003) The role of information and social interactions in retirement plan decisions: evidence from a randomized experiment. Q J Econ 118(3):815–842
Frank RH (1985) Choosing the right pond: human behavior and the quest for status. Oxford University Press, New York, NY
Freeman LC (1978) Centrality in social networks—conceptual clarification. Soc Networks 19:209–222
Godes D (2011) Invited comment on “opinion leadership and social contagion in new product diffusion”. Mark Sci 30(2):224–229
Godes D, Mayzlin D (2004) Firm-created word-of-mouth communication: a field-based quasiexperiment. HBS Marketing Research Paper No. 04–03. http://ssrn.com/abstract = 569361
Goldstein J (2009) The long decline of drug sales reps. Wall Street Journal Health Blog, 23 Mar 2009
Granovetter M (1978) Threshold models of collective behavior. Am J Sociol 83(6):1420–1443
Iyengar R, Valente T, Van den Bulte C (2011) Opinion leadership and social contagion in new product diffusion. Mark Sci 30(2):195–212
Lomas J, Enkin M, Anderson GM, Hannah WJ, Vadya E, Singer J (1991) Opinion leaders vs. audit and feedback to implement practice guidelines. J Am Med Assoc 265(17):2202–2207
Manchanda P, Xie Y, Youn N (2008) The role of targeted communication and contagion in new product adoption. Mark Sci 27(6):961–976
Manski CF (1993) Identification of endogenous social effects: the reflection problem. Rev Econ Stud 60(3):531–542
McKee P (2010) Decline in pharma rep sales force: what pharmaceutical companies will do next. PHC Consulting. http://www.phcconsulting.com. Accesssed 7 Apr 2010
Nair H, Manchanda P, Bhatia T (2010) Asymmetric social interactions in physician prescription behavior: the role of opinion leaders. J Mark Res 47(5):883–895
Nam S, Manchanda P, Chintagunta PK (2010) The effects of service quality and word-of-mouth on customer acquisition, retention and usage. Mark Sci 29(4):690–700
Reingen PH, Kernan JB (1986) Analysis of referral networks in marketing: methods and illustration. J Mark Res 23(11):370–378
Sacerdote B (2001) Peer effects with random assignment: results for Dartmouth roommates. Q J Econ 116(2):681–704
Schelling T (1971) Dynamic models of segregation. J Math Sociol 1:143–186
Stokman FN (2001) Networks: social. International Encyclopedia of Social and Behavioral Sciences, Elsevier Science Ltd., Amsterdam, pp 10509–10514
Stremersch S, Van Dyke W (2009) Marketing of the life sciences: a new framework and research agenda for a nascent field. J Mark 73(7):1–42
Stremersch S, Lehmann DR, Dekimpe MG (2010) Editorial: preface to “the chilling effect of network externalities”. Int J Res Mark 27(1):1–3
Trusov M, Bodapati AV, Bucklin RV (2010) Determining influential users in internet social networks. J Mark Res 47(4):643–658
Valente TH, Hoffman BR, Ritt-Olson A, Lichtman K, Johnson CA (2003) Effects of a social-network method for group assignment strategies on peer-led tobacco prevention programs in schools. Am J Public Health 93(11):1837–1843
Van den Bulte C, Lilien GL (2001) Medical innovation revisited: social contagion versus marketing effort. Am J Sociol 106(5):1409–1435
Wuyts S, Dekimpe M, Gijsbrechts E, Pieters R (2010) The connected customer: the changing nature of consumer and business markets. Routledge, London
Yang S, Allenby GM (2003) Modeling interdependent consumer preferences. J Mark Res 40(3):282–294
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bhatia, T. (2014). Leveraging Peer-to-Peer Networks in Pharmaceutical Marketing. In: Ding, M., Eliashberg, J., Stremersch, S. (eds) Innovation and Marketing in the Pharmaceutical Industry. International Series in Quantitative Marketing, vol 20. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7801-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7801-0_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7800-3
Online ISBN: 978-1-4614-7801-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)